The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute ...

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies ...

Each organ in the human body contains different types of cells arranged in specific ways.These arrangements aid protein interactions, which drive ...

Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded by 3.6% YoY to 42.7% ...

There is no cure for congenital erythropoietic porphyria, but after years of work and patient collaboration, a potential drug ...

The global Zoonotic Disease Treatment Market, valued at USD 46.4 billion in 2025, is projected to grow to USD 82.3 billion by ...